Can Acyclovir Cause Yeast Infections?
Maintaining our health often requires navigating a complex web of medications and their potential side effects. Acyclovir, a commonly prescribed antiviral medication,... Read more.
Exploring the Relationship Between Orphenadrine and Sperm Quality
Maintaining reproductive health is a crucial aspect of overall well-being, and various factors can influence fertility. The prevalence of sperm quality issues varies... Read more.
FDA Issues Warning on Toxic Tejocote Root Supplements Contaminated with Yellow Oleander
In September 2023, the Centers for Disease Control and Prevention published a report of several tejocote root products found to be substituted with toxic yellow... Read more.
Megadyne Medical Products, Inc. Issues Recall for Mega Soft Universal Patient Return Electrode Due to Burn Risks
Megadyne Medical Products, Inc. has initiated a recall of its Mega Soft Universal Patient Return Electrode, Mega Soft Universal Dual, Mega Soft Universal Plus, and... Read more.
FDA Approves Vaporized Hydrogen Peroxide as Established Sterilization Method for Medical Devices
In a significant development, the U.S. Food and Drug Administration (FDA) has officially recognized vaporized hydrogen peroxide (VHP) as an established method of... Read more.
Chiesi Group and Oak Hill Bio Collaborate on OHB-607, a Neonatal Therapy
Chiesi Group, an international biopharmaceutical and healthcare group, and Oak Hill Bio, a neonatology and rare disease therapeutics company, have entered into a... Read more.
AbbVie Introduces PRODUODOPA® for Advanced Parkinson’s Disease in the European Union
AbbVie (NYSE: ABBV), a leading global healthcare company, has announced the launch of PRODUODOPA® (foslevodopa/foscarbidopa) in the European Union. This innovative... Read more.
Medtronic’s Percept™ RC Neurostimulator, Empowered by BrainSense™ Technology, Receives FDA Approval
Medtronic plc, a global leader in healthcare technology, proudly announced today the approval of its Percept™ RC Deep Brain Stimulation (DBS) system by the U.S.... Read more.
Bayer Pushes Forward with U.S. Expansion Despite Setback in Blood Thinner Drug Development
German pharmaceutical giant Bayer (BAYGn.DE) remains undeterred in its plans for expansion into the U.S., reaffirming its commitment to the market despite the setback... Read more.
GSK Expands Respiratory Portfolio through $1.4 Billion Aiolos Bio Deal
British pharmaceutical giant GlaxoSmithKline (GSK) announced a strategic move to bolster its respiratory diseases portfolio with the acquisition of Aiolos Bio for... Read more.